NDC 68071-2240-01 - CARBIDOPA AND LEVODOPA

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 68071-2240
Requested NDC: 68071-2240-01
Package NDCs from labels: 68071-2240-1, 68071-2240-01
Manufacturer: NuCare Pharmaceuticals,Inc.
Effective date: 2024-07-17
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Carbidopa and Levodopa Tablets, USP	NuCare Pharmaceuticals,Inc.	2024-07-17	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68071-2240-1	CARBIDOPA AND LEVODOPA	100 in 1 BOTTLE	TABLET	100		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-2240	CARBIDOPA AND LEVODOPA TABLET [NUCARE PHARMACEUTICALS,INC.]	3	Current NDC, Legacy NDC, 1 package rows	20240719_ad2ab0c4-188b-f025-e053-2a95a90a2816.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 6 · 106 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Carbidopa	CARBIDOPA	Aurobindo Pharma Limited	ed98c7e1-78a6-43a5-92cd-4f085af6f09d	2021-04-29	Warnings, Adverse reactions	Exact identifier unii: MNX7R8C5VO
Carbidopa	CARBIDOPA TABLETS	Oceanside Pharmaceuticals	d5204e5e-10ef-4758-8fc6-cb710048c687	2020-07-02	Warnings, Adverse reactions	Exact identifier unii: MNX7R8C5VO
Lodosyn	CARBIDOPA	Bausch Health US, LLC	ff8e105b-7415-42d4-bbb2-b36cfb8945a5	2020-07-01	Warnings, Adverse reactions	Exact identifier unii: MNX7R8C5VO
Carbidopa and Levodopa	CARBIDOPA AND LEVODOPA	Alembic Pharmaceuticals Limited	a85a56c5-44dd-41d4-ac1c-bdc4758406a4	2019-06-06	Warnings, Adverse reactions	Exact identifier unii: MNX7R8C5VO unii: 46627O600J
Neuro-Pro T007	GABA, L-DOPA, NOREPINEPHRINE, SEROTONIN, ADRENOCORTICOTROPHIN, ANACARDIUM ORIENTALE, ARSENICUM ALBUM, BARYTA CARBONICA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, HYOSCYAMUS NIGER, LYCOPODIUM CLAVATUM, STRAMONIUM	Guangzhou Renuma Medical Systems Co., Ltd	7e02ab0c-9bc2-4ffe-926c-5b388a07f7b2	2017-10-18	Warnings	Exact identifier unii: 46627O600J
Carbidopa	CARBIDOPA	Novel Laboratories, Inc.	7e5c9666-7a7c-4b64-87e4-7be6ae53603e	2017-06-01	Warnings, Adverse reactions	Exact identifier unii: MNX7R8C5VO

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.